The role of nitric oxide in soman-induced seizures, neuropathology, and lethality

Pharmacology Biochemistry and Behavior

Volumn 54, Issue 4, 1996, Pages 731-737

  Lallement, Guy ^a   Shih, Tsung Ming ^b   Pernot Marino, Irmine ^a   Baubichon, Dominique ^a   Foquin, Annie ^a   McDonough, John H ^b  

^a CENTRE DE RECHERCHES   (France)

^b Biochemical Pharmacology   (United States)

Author keywords

Glyceryl trinitrate; Nitric oxide; Nitric oxide synthase inhibitors; Seizures; Soman

Indexed keywords

7 NITROINDAZOLE; GLYCERYL TRINITRATE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; SOMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; EPILEPSY; INTRAPERITONEAL DRUG ADMINISTRATION; LETHALITY; MALE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

ANIMALIA;

EID: 0030219894     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02223-6     Document Type: Article

References (37)

1. 1. Bagetta, G.; Iannone, M.; Scorsa, A. M.; Nistico, G. Tacrine-induced seizures and brain damage in LiCl-treated rats can be prevented by N-nitro-L-arginine methyl ester. Eur. J. Pharmacol. 213:301-304; 1992.
2. 2. Blanchet, G.; Carpentier, P.; Lallement, G.; Tarricone, A.; Sentenac, H.; Kamenka, J. M. Anticonvulsant effect of TCP in soman poisoning. In: Kamenka, J. M.; Domino, E. F., eds. Multiple sigma and PCP receptor ligands: Mechanisms for neuromodulation and neuroprotection. Ann Arbor, MI: NPP Books; 1992:831-840.
3. 3. Bredt, D. S.; Snyder, S. H. Nitric oxide, a novel neuronal messenger. Neuron 8:3-11; 1992.
4. 4. Buisson, A.; Lakhmeche, N.; Verreccgua, C.; Plotkine, M.; Boulu, R. G. Nitric oxide: An endogenous anticonvulsant substance. Neuroreport 4:444-446; 1993.
5. 5. De Sarro, G. B.; Di Paola, E. D.; De Sarro, A.; Vidal, M. J. L-Arginine potentiates excitatory amino acid-induced seizures elicited in the deep prepiriform cortex. Eur. J. Pharmacol. 230:151-158; 1993.
6. 6. De Sarro, G. B.; Di Paola, E. D.; De Sarro, A.; Vidal, M. J. Role of nitric oxide in the genesis of excitatory amino acid-induced seizures from the deep prepiriform cortex. Fundam. Clin. Pharmacol. 5:503-511; 1991.
7. 7. Garthwaite, J. Glutamate, nitric oxide and cell-cell signalling in the nervous systems. Trends Neurosci. 14:60-67; 1991.
8. 8. Haberny, K. A.; Pou, S.; Eccles, C. U. Potentiation of quinolinate-induced hippocampal lesions by inhibition of NO synthesis. Neurosci. Lett. 146:187-190; 1992.
9. 9. Iadecola, C. Regulation of the cerebral microcirculation during neural activity: Is nitric oxide the missing link. Trends Neurosci. 16:206-214; 1993.
10. 10. Kelly, P. A. T.; Ritchie, I. M.; Arbuthnott, G. W. 7-Nitro indazole uncouples cerebral blood flow from metabolic demand in the conscious rat. Br. J. Pharmacol. Suppl. 112:348P; 1994.
11. 11. Lallement, G.; Carpentier, P.; Collet, A.; Baubichon, D.; Pernot-Marino, I.; Blanchet, G. Extracellular acetylcholine changes in rat limbic structures during soman-induced seizures. Neurotoxicology 13:557-568; 1992.
12. 12. Lallement, G.; Carpentier, P.; Pernot-Marino, I.; Baubichon, D.; Collet, A.; Blanchet, G. Involvement of the different rat hippocampal glutamatergic receptors in development of seizures induced by soman: An autoradiographic study. Neurotoxicology 12:655-664; 1991.
13. 13. Lallement, G.; Delamanche, I. S.; Pernot-Marino, I.; Baubichon, D.; Denoyer, M.; Carpentier, P.; Blanchet, G. Neuroprotective activity of glutamate receptor antagonists against soman-induced hippocampal damage: Quantification with an ω3 site ligand. Brain Res. 618:227-237; 1993.
14. 14. Lallement, G.; Pernot-Marino, I.; Foquin-Tarricone, A.; Baubichon, D.; Piras, A.; Blanchet, G.; Carpentier, P. Coadministration of atropine, NBQX and TCP against soman-induced seizures. Neuroreport 5:1113-1117; 1994.
15. 15. Lei, S. Z.; Pan, Z. H.; Aggarwal, S. K.; Chen, H. S. V.; Hartman, J.; Sucher, N. J.; Lipton, S. A. Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron 8:1087-1099; 1992.
16. 16. Lipton, S. A.; Choi, Y. B.; Pan, Z. H.; Lei, S. Z.; Chen, H. S. V.; Sucher, N. J.; Loscalzo, J.; Singel, D. J.; Stamler, J. S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364:626-632; 1993.
17. 17. MacKenzie, G. M.; Rose, S.; Bland-Ward, P. A.; Moore, P. K.; Jenner, P.; Marsden, C. D. Time course of inhibition of brain nitric oxide synthase by 7-nitroindazole. Neuroreport 5:1993-1996; 1994.
18. 18. Manchester, K. S.; Jensen, F. E.; Warach, S.; Lipton, S. A. Chronic administration of nitroglycerin decreases cerebral infarct size. Neurology 43:798P; 1993.
19. 19. Manzoni, O.; Prezeau, L.; Marin, P.; Deshager, S.; Bockaert, J.; Fagni, L. Nitric oxide-induced blockade of NMDA receptors. Neuron 8:653-662; 1992.
20. 20. Marks, G. S.; McLaughlin, B. E.; Nakatsu, K.; Brien, J. Biotransformation of glyceryl trinitrate by rat brain homogenate. Can. J. Physiol. Pharmacol. 70:935-937; 1992.
21. 21. McDonough, J. H.; Shih, T.-M. Pharmacological modulation of soman-induced seizures. Neurosci. Biobehav. Rev. 17:203-215; 1993.
22. 22. Mollace, V.; Begetta, G.; Nistico, G. Evidence that L-arginine possesses proconvulsant effects mediated through nitric oxide. Neuroreport 2:269-272; 1991.
23. 23. Nathan, C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051-3064; 1992.
24. 24. Paxinos, G.; Watson, C. The rat brain in stereotaxic coordinates. New York: Academic Press Inc.; 1982.
25. 25. Penix, L. P.; Davis, W.; Subramaniam, S. Inhibition of NO synthase increases the severity of kainic acid-induced seizures in rodents. Epilepsy Res. 18:177-184; 1994.
26. 26. Przegalinski, E.; Baran, L.; Siwanowicz, J. The role of nitric oxide in the kainate-induced seizures in mice. Neurosci. Lett. 170: 74-76; 1994.
27. 27. Rigaud, A. S.; Pinard, E.; Charbonne, R.; Heron, A.; Seylaz, J. Crucial role of NO in the increase in cerebral blood flow during seizures. J. Cereb. Blood Flow Metab. 13:S167; 1993.
28. 28. Rondouin, G.; Bockaert, J.; Lerner-Natoli, M. L-nitroarginine, an inhibitor of NO synthase, dramatically worsens limbic epilepsy in rats. Neuroreport 4:1187-1190; 1993.
29. 29. Rondouin, G.; Lerner-Natoli, M.; Manzoni, O.; Lafon-Cazal, M.; Bockaert, J. A nitric oxide (NO) synthase inhibitor accelerates amygdala kindling. Neuroreport 3:805-808; 1992.
30. 30. Shih, T.-M. Time course effects of soman on acetylcholine and choline levels in six discrete areas of the rat brain. Psychopharmacology (Berlin) 78:170-175; 1982.
31. 31. Shih, T.-M.; Scremin, O. U. Cerebral blood flow and metabolism in soman-induced convulsions. Brain Res. Bull. 28:735-742; 1992.
32. 32. Snyder, S. H.; Bredt, D. S. Nitric oxide as a neuronal messenger. Trends Pharmacol. Sci. 12:125-128; 1991.
33. 33. Starr, M. S.; Starr, B. S. Paradoxical facilitation of pilocarpine-induced seizures in the mouse by MK-801 and the nitric oxide synthesis inhibitor L-NAME. Pharmacol. Biochem. Behav. 45:321-325; 1993.
34. 34. Switzer, R. C. Silver staining methods: Their role in detecting neurotoxicity. In: Johannessen, J. N., eds. Markers of neuronal injury and degeneration. New York: Annals of the New York Academy of Sciences; 1993:341-348.
35. 35. Tanaka, K.; Cotoh, F.; Gomi, S.; Takashima, S.; Mihara, B.; Shirai, T.; Nogawa, S.; Nagata, I. Inhibition of NO synthesis induces a significant reduction in local cerebral blood flow in the rat. Neurosci. Lett. 127:129-132; 1991.
36. 36. Torfgard, K.; Ahlner, J. Tissue levels of glyceryl trinitate and cGMP after in vivo administration in rat, and the effect of tolerance development. Can. J. Physiol. Pharmacol. 69:1257-1261; 1991.
37. 37. Wang, Q.; Paulson, O. B.; Lassen, N. A. Effect of NO blockade by N-nitro-L-arginine on cerebral blood flow response to changes in carbon dioxide tension. J. Cereb. Blood Flow Metab. 12:947-953; 1992.